Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BriaCell Reports Extended Progression-Free Survival To 9.1 Months In ADC Resistant Metastatic Breast Cancer Patient; Top Responder Continues Bria-IMT Treatment In Phase 2 Study

Author: Benzinga Newsdesk | July 18, 2024 07:58am

Previously Reported Significant Reduction Of "Eye-Bulging" Tumor; Patient Had Failed 8 Prior Regimens

Posted In: BCTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist